Dr. Njira Lugogo discusses the use of biologic agents in severe asthma, reviewing the approach to management, biomarker use, and specific inflammatory cascade targets. A discussion of real-world trial data…

INHALE has added a smoking status code to the list of codes that are required to include patients into the Tobacco Cessation Counseling Denominator. The addition of this code will…

Asthma is an everyday part of life for many people. But it’s a diverse condition, and everyone has their own experience with it. This sometimes makes managing asthma a little…

September is a peak time for asthma attacks in the United States. According to the Allergy and Asthma Network, this is when emergency department visits and hospital admissions for asthma…

INHALE is pleased to share details on a new, free educational resource American Lung Association (ALA) is offering through their Lung HelpLine, Lung Health Education Series.

Listen and learn from Dr. Reuben Strayer, emergency medicine physician in New York, about how providers can improve their patient outcomes by replacing Albuterol rescue inhalers.

The report is updated yearly and is based, to the best of the group’s ability, on current best evidence, medical knowledge, and practice. Since 2019, when there was a major…

The 2024 and 2025 timelines are now available, view them here. We have split the timelines into Cohort 1 (PO's starting in 2022) and Cohort 2 (POs starting in 2024).…

Teva Pharmaceuticals is discontinuing its series of digital inhalers starting June 1, 2024. Teva’s digital inhalers include: ProAir® Digihaler® (albuterol sulfate) inhalation powderArmonAir® Digihaler® (fluticasone propionate) inhalation powderAirDuo® Digihaler® (fluticasone…

Drug companies Boehringer Ingelheim, AstraZeneca and GSK have announced they are capping out-of-pocket costs for their inhaler products at $35 per month. INHALE applauds all three companies for their decision!…

BCBSM Update BCBSM approves Flovent ABA for members less than 5 years of age. No prior authorization needed for the 44mcg HFA to bridge coverage due to the Amsmanex inhaler…

General Update Flovent HFA and Flovent Diskus are inhaled corticosteroid medicines used as a controller medicine to treat asthma. Flovent HFA is also used to treat eosinophilic esophagitis (EoE). Glaxo…

The INHALE Patient Advisory Board assembled for its first virtual meeting on November 9th. At this meeting, the group discussed goals of the board, operating norms, meeting cadence, and each advisor’s “why”…